3,001 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by Venturi Wealth Management LLC

Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,001 shares of the pharmacy operator’s stock, valued at approximately $28,000.

Several other hedge funds also recently bought and sold shares of WBA. First Financial Corp IN lifted its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $26,000. TD Private Client Wealth LLC lifted its position in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares during the last quarter. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $30,000. Finally, Brooklyn Investment Group acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $35,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

WBA opened at $11.04 on Thursday. The stock’s 50 day simple moving average is $10.44 and its 200-day simple moving average is $9.71. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market cap of $9.54 billion, a PE ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.66 EPS. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

WBA has been the subject of several analyst reports. Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Bank of America upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday. Finally, Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $12.63.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.